Opko Sees Huge Long-Term Impact From Prolor Deal

Aug. 21 (Bloomberg) -- Phillip Frost, chief executive officer of Opko Health Inc., talks about its share listing on the Tel Aviv Stock Exchange today and the acquisition of Israeli drugmaker Prolor Biotech Inc. He speaks with Elliott Gotkine on Bloomberg Television's "On the Move." (Source: Bloomberg)
H-Shares Valuations Still Attractive: UBS Wealth's Tay
18:36 - Kelvin Tay, Singapore-based chief investment officer for Southern Asia Pacific at UBS Wealth Management, talks about China's stocks and central bank policy. Tay also discusses Greece's debt problems and their implications for European and Asian markets. He speaks with Yvonne Man on Bloomberg Television's "First Up." (Source: Bloomberg)
  • China A-Shares in Bear Market as Index Falls 22%
  • AOL to Take Over Microsoft's Display Ad Business
  • Greece Needs Monti-Like Bureaucratic Government: Jakobsen